These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
901 related articles for article (PubMed ID: 11454688)
1. Tumor growth inhibition by arsenic trioxide (As2O3) in the orthotopic metastasis model of androgen-independent prostate cancer. Maeda H; Hori S; Nishitoh H; Ichijo H; Ogawa O; Kakehi Y; Kakizuka A Cancer Res; 2001 Jul; 61(14):5432-40. PubMed ID: 11454688 [TBL] [Abstract][Full Text] [Related]
2. The role of p38 MAPK and JNK in Arsenic trioxide-induced mitochondrial cell death in human cervical cancer cells. Kang YH; Lee SJ J Cell Physiol; 2008 Oct; 217(1):23-33. PubMed ID: 18412143 [TBL] [Abstract][Full Text] [Related]
3. Arsenic trioxide induces apoptosis through JNK and ERK in human mesothelioma cells. Eguchi R; Fujimori Y; Takeda H; Tabata C; Ohta T; Kuribayashi K; Fukuoka K; Nakano T J Cell Physiol; 2011 Mar; 226(3):762-8. PubMed ID: 20799280 [TBL] [Abstract][Full Text] [Related]
4. Guggulsterone-induced apoptosis in human prostate cancer cells is caused by reactive oxygen intermediate dependent activation of c-Jun NH2-terminal kinase. Singh SV; Choi S; Zeng Y; Hahm ER; Xiao D Cancer Res; 2007 Aug; 67(15):7439-49. PubMed ID: 17671214 [TBL] [Abstract][Full Text] [Related]
5. Protoapigenone, a novel flavonoid, induces apoptosis in human prostate cancer cells through activation of p38 mitogen-activated protein kinase and c-Jun NH2-terminal kinase 1/2. Chang HL; Wu YC; Su JH; Yeh YT; Yuan SS J Pharmacol Exp Ther; 2008 Jun; 325(3):841-9. PubMed ID: 18337475 [TBL] [Abstract][Full Text] [Related]
6. C-Jun N-terminal kinase is required for phorbol ester- and thapsigargin-induced apoptosis in the androgen responsive prostate cancer cell line LNCaP. Engedal N; Korkmaz CG; Saatcioglu F Oncogene; 2002 Feb; 21(7):1017-27. PubMed ID: 11850819 [TBL] [Abstract][Full Text] [Related]
7. The novel antimicrotubule agent cryptophycin 52 (LY355703) induces apoptosis via multiple pathways in human prostate cancer cells. Drew L; Fine RL; Do TN; Douglas GP; Petrylak DP Clin Cancer Res; 2002 Dec; 8(12):3922-32. PubMed ID: 12473608 [TBL] [Abstract][Full Text] [Related]
8. Pharmacologic inhibitors of extracellular signal-regulated kinase (ERKs) and c-Jun NH(2)-terminal kinase (JNK) decrease glutathione content and sensitize human promonocytic leukemia cells to arsenic trioxide-induced apoptosis. Ramos AM; Fernandez C; Amrán D; Esteban D; de Blas E; Palacios MA; Aller P J Cell Physiol; 2006 Dec; 209(3):1006-15. PubMed ID: 16972261 [TBL] [Abstract][Full Text] [Related]
9. Indomethacin induces apoptosis in 786-O renal cell carcinoma cells by activating mitogen-activated protein kinases and AKT. Ou YC; Yang CR; Cheng CL; Raung SL; Hung YY; Chen CJ Eur J Pharmacol; 2007 Jun; 563(1-3):49-60. PubMed ID: 17341418 [TBL] [Abstract][Full Text] [Related]
10. Novel human neutrophil agonistic properties of arsenic trioxide: involvement of p38 mitogen-activated protein kinase and/or c-jun NH2-terminal MAPK but not extracellular signal-regulated kinases-1/2. Binet F; Girard D J Leukoc Biol; 2008 Dec; 84(6):1613-22. PubMed ID: 18728151 [TBL] [Abstract][Full Text] [Related]
11. The effect of MAPK inhibitors on arsenic trioxide-treated Calu-6 lung cells in relation to cell death, ROS and GSH levels. Han YH; Moon HJ; You BR; Kim SZ; Kim SH; Park WH Anticancer Res; 2009 Oct; 29(10):3837-44. PubMed ID: 19846917 [TBL] [Abstract][Full Text] [Related]
12. Calcium-mediated activation of c-Jun NH2-terminal kinase (JNK) and apoptosis in response to cadmium in murine macrophages. Kim J; Sharma RP Toxicol Sci; 2004 Oct; 81(2):518-27. PubMed ID: 15254339 [TBL] [Abstract][Full Text] [Related]
13. Arsenic trioxide induces apoptosis through a reactive oxygen species-dependent pathway and loss of mitochondrial membrane potential in HeLa cells. Woo SH; Park IC; Park MJ; Lee HC; Lee SJ; Chun YJ; Lee SH; Hong SI; Rhee CH Int J Oncol; 2002 Jul; 21(1):57-63. PubMed ID: 12063550 [TBL] [Abstract][Full Text] [Related]
14. ASK1 is activated by arsenic trioxide in leukemic cells through accumulation of reactive oxygen species and may play a negative role in induction of apoptosis. Yan W; Arai A; Aoki M; Ichijo H; Miura O Biochem Biophys Res Commun; 2007 Apr; 355(4):1038-44. PubMed ID: 17331470 [TBL] [Abstract][Full Text] [Related]
15. Opposite effect of ERK1/2 and JNK on p53-independent p21WAF1/CIP1 activation involved in the arsenic trioxide-induced human epidermoid carcinoma A431 cellular cytotoxicity. Huang HS; Liu ZM; Ding L; Chang WC; Hsu PY; Wang SH; Chi CC; Chuang CH J Biomed Sci; 2006 Jan; 13(1):113-25. PubMed ID: 16283431 [TBL] [Abstract][Full Text] [Related]
16. Modulation of arsenic trioxide-induced apoptosis by genistein and functionally related agents in U937 human leukaemia cells. Regulation by ROS and mitogen-activated protein kinases. Sánchez Y; Calle C; de Blas E; Aller P Chem Biol Interact; 2009 Nov; 182(1):37-44. PubMed ID: 19720055 [TBL] [Abstract][Full Text] [Related]
17. Arsenic trioxide (As2O3) inhibits invasion of HT1080 human fibrosarcoma cells: role of nuclear factor-kappaB and reactive oxygen species. Park MJ; Lee JY; Kwak HJ; Park CM; Lee HC; Woo SH; Jin HO; Han CJ; An S; Lee SH; Chung HY; Park IC; Hong SI; Rhee CH J Cell Biochem; 2005 Aug; 95(5):955-69. PubMed ID: 15962302 [TBL] [Abstract][Full Text] [Related]
18. Inhibition on LS-174T cell growth and activity of telomerase in vitro and in vivo by arsenic trioxide. Wang X; Wang G; Dong D; Fu S; Yang B Exp Toxicol Pathol; 2008 Sep; 60(6):481-8. PubMed ID: 18606528 [TBL] [Abstract][Full Text] [Related]
19. Dual effects of glutathione-S-transferase pi on As2O3 action in prostate cancer cells: enhancement of growth inhibition and inhibition of apoptosis. Lu M; Xia L; Luo D; Waxman S; Jing Y Oncogene; 2004 May; 23(22):3945-52. PubMed ID: 15007384 [TBL] [Abstract][Full Text] [Related]
20. Arsenic trioxide triggers a regulated form of caspase-independent necrotic cell death via the mitochondrial death pathway. Scholz C; Wieder T; Stärck L; Essmann F; Schulze-Osthoff K; Dörken B; Daniel PT Oncogene; 2005 Mar; 24(11):1904-13. PubMed ID: 15674346 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]